New diagnostic tests: more harm than good | The BM...

mgraber graber.mark at GMAIL.COM
Thu Jul 20 16:46:23 UTC 2017

Thanks to Stephen Martin for forwarding this new article from Bjorn Hofmann and Gilbert Welch that looks at the benefits vs harms (and cost) of 4 new tests:  immunosignature testing, breath tests for lung cancer, patch vital sign monitoring, and biomarkers for Alzheimer’s disease.  The title of the article summarizes their conclusions.


Mark L Graber, MD FACP

President, SIDM

Senior Fellow, RTI International

Professor Emeritus, Stony Brook University, NY


Moderator: David Meyers, Board Member, Society to Improve Diagnosis in Medicine

HTML Version:
URL: <../attachments/20170720/450e340c/attachment.html> ATTACHMENT:
Name: image001.png Type: image/png Size: 22016 bytes Desc: not available URL: <../attachments/20170720/450e340c/attachment.png>

More information about the Test mailing list